SUBSCRIBE
SUBSCRIBE

Sound Pharmaceuticals

NEWS
Drug Development
2021 COVID-19 News: Breakthrough Cases, Children’s Viral Load and More
Please check out the biopharma industry’s COVID-19 stories that are trending for April 13, 2021.
April 13, 2021
 · 
4 min read
 · 
BioSpace Editorial Staff
bakdc/Shutterstock
Drug Development
NIH to Back First Phase II Trials for COVID-19 Therapy Targeting Viral Proteases
The $3.1 million NCATS grant will help the company test SPI-1005 in two trials, both OK’d by the U.S. Food and Drug Administration (FDA) last August.
April 7, 2021
 · 
2 min read
 · 
Mark Zipkin
IN THE PRESS
Press Releases
Sound Pharma to Present at Upcoming Life Sciences Industry Conferences
July 9, 2025
 · 
2 min read
Press Releases
Sound Pharma to Present at Upcoming Life Science Investor Conferences
April 8, 2025
 · 
2 min read
Press Releases
Sound Pharma to Present SPI-1005 Preclinical and Clinical Hearing Loss and Tinnitus Data at the Defense Health Agency Hearing Center of Excellence Symposia and ARO MWM
February 18, 2025
 · 
3 min read
Press Releases
Sound Pharma Announces Positive Phase 3 Results for the Treatment of Meniere’s Disease with SPI-1005
December 10, 2024
 · 
5 min read
BioForest
Sound Pharmaceuticals’ IND Involving Cochlear Implantation Allowed by the FDA
May 20, 2024
 · 
3 min read
BioForest
Sound Pharma to present positive interim data from its Phase 2b Cystic Fibrosis STOP Ototoxicity Trial
January 30, 2024
 · 
2 min read
Drug Development
Sound Pharma completes enrollment in pivotal Phase 3 clinical trial of SPI-1005 for the treatment of Meniere’s disease involving hearing loss, tinnitus, and dizziness.
May 3, 2023
 · 
4 min read
Drug Development
Sound Pharma initiates enrollment in pivotal Phase 3 clinical trial of SPI-1005 for the treatment of hearing loss and tinnitus in Meniere’s disease
July 28, 2022
 · 
5 min read
BioForest
Sound Pharmaceuticals’ NIH Grant for a novel oral COVID-19 treatment increases to $4.2M
May 11, 2022
 · 
2 min read
Drug Development
Sound Pharmaceuticals awarded $3.1M NIH grant to test SPI-1005 in COVID-19
April 6, 2021
 · 
2 min read
Load More
JOBS